EZR and esophageal squamous cell carcinoma: Furthermore, Zhan et al. demonstrated that LOXL2 promoted the esophageal squamous cell carcinoma (ESCC) metastasis by inducing ezrin phosphorylation-mediated cytoskeletal reorganization53.